Related Experiment Videos
Folate-PEG-folate-graft-polyethylenimine-based gene delivery
J M Benns1, A Maheshwari, D Y Furgeson
1Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, 30 South 2000 East, RM 201, Salt Lake City, UT 84112-5820, USA.
Journal of Drug Targeting
|November 8, 2001
Summary
This study developed folate-polyethylene glycol-folate-grafted-polyethylenimine (FPF-g-PEI) for gene delivery. The novel FPF-g-PEI demonstrated superior transfection efficiency and lower toxicity in cancer cells compared to unmodified polyethylenimine (PEI).
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Delivery Systems
Background:
- Polyethylenimine (PEI) is a common gene delivery vector but suffers from high toxicity.
- Folic acid receptor-mediated targeting can enhance gene delivery specificity to cancer cells.
- Functionalized PEI carriers are needed to improve safety and efficacy.
Purpose of the Study:
- To synthesize and characterize folate-polyethylene glycol-folate-grafted-polyethylenimine (FPF-g-PEI) as a novel gene delivery vector.
- To evaluate the transfection efficiency and cytotoxicity of FPF-g-PEI in cancer cells and normal cells.
- To assess the therapeutic potential of FPF-g-PEI for gene expression.
Main Methods:
- FPF-g-PEI synthesis and characterization (graft ratio, molecular weight, pH profile).
- Plasmid DNA condensation and polyplex characterization (AFM, DLLS).
- In vitro transfection efficiency assays in smooth muscle cells (SMC) and CT-26 colon adenocarcinoma cells.
- Cytotoxicity assessment using MTT assay.
- Gene expression analysis (protein and mRNA) using ELISA and RT-PCR.
Main Results:
- FPF-g-PEI was successfully synthesized with 2.3 folate-PEG-folate grafts per PEI molecule, average MW ~33,500.
- FPF-g-PEI and PEI formed polyplexes ~150 nm in diameter, suitable for gene delivery.
- FPF-g-PEI exhibited significantly higher transfection efficiency and lower cytotoxicity in CT-26 cancer cells compared to PEI.
- No folate-specific targeting was observed in smooth muscle cells; PEI showed higher efficiency.
Conclusions:
- FPF-g-PEI represents a promising, less toxic gene delivery vector for cancer therapy.
- Folate conjugation enhances gene delivery to cancer cells, but specificity in normal cells requires further investigation.
- The developed FPF-g-PEI carrier holds potential for therapeutic gene expression applications.